Heart drug may tame baby blood vessel growth
NCT ID NCT00744185
First seen Jun 02, 2026 · Last updated Jun 11, 2026 · Updated 1 time
Summary
This study tested the drug propranolol in infants under 4 months old with capillary hemangiomas (non-dangerous blood vessel growths). The goal was to see if early treatment could shrink the growths. The study was stopped early and only 14 infants took part, so results are limited.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEMANGIOMA, CAPILLARY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Dermatologie Pédiatrique
Bordeaux, 33 076, France
Conditions
Explore the condition pages connected to this study.
Conditions inferred from the trial description
These were inferred from the trial's summary, not listed by the trial registrant.